Monograph
J01DD08 - Cefixime |
Propably not porphyrinogenic |
PNP |
Rationale
Probably not significantly metabolised. Conflicting references.
Chemical description
Perorally administered cephalosporin (200 mg x 2) used in pharyngotonsillitis, otitis media and sinusitis where treatment with penicillins have shown to be without effect. About 20 % of an oral dose (or 50 % of the absorbed dose) is excreted unchanged in urine within 24 hours. Up to 60% may be eliminated by non-renal mechanisms. There is no evidence of metabolism but some of the drug is probabably ecreted via bile. South African list: use with caution . French list: use.
IPNet drug reports
Uneventful use reported in 2 patients with acute porphyria.
Similar drugs
Tradenames
This list comprises raw data collected from different countries.
In some cases, a more comprehensive list of available drug packages is included.
Consequently, very similar terms may therefore appear multiple times.
Bold names are the searchable terms, while the gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Cefixima · Denvar 
Cefixima · Cefixoral · Stadium · Supracef · Unixime 
Cefixima · Cefixima Codal · Eficef · Xifia 
Cefixime · Suprax · Suprax Paediatric 
Infecto-Opticef 
Cetix 
Cefapan · Pancef
© NAPOS 2025